PUBLISHER: The Business Research Company | PRODUCT CODE: 1274393
PUBLISHER: The Business Research Company | PRODUCT CODE: 1274393
“Gene Expression Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on gene expression market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for gene expression? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The gene expression market global report ” from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of COVID-19 on supply chains and consumption patterns.
Major players in the gene expression market are Thermo Fisher Scientific Inc., Qiagen NV, Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., PerkinElmer Inc., GE HealthCare, F. Hoffmann-La Roche Ltd., Oxford Gene Technology IP Limited, Promega Corporation, Quest Diagnostics Inc., Interpace Biosciences Inc., OriGene Technologies, Luminex Corporation, Takara Bio Inc., Danaher Corporation, ELITechGroup, AutoGenomics Inc., Biocartis Group NV, Integragen SA, Oxford Nanopore Technologies Limited, and Phalanx Biotech Group.
The global gene expression market is expected to grow from $9.49 billion in 2022 to $10.51 billion in 2023 at a compound annual growth rate (CAGR) of 10.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The gene expression market is expected to grow to $15.56 billion in 2027 at a CAGR of 10.3%.
The gene expression market includes revenues earned by entities by providing services such as transcription, mRNA processing, non-coding RNA maturation, RNA export, translation, folding, translocation, and protein transport. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
Gene expression refers to the process by which the information encoded from a gene is used in the production of a functional product, like a protein. They are used for directing the assembly of a protein molecule and proteins dictate the cell function.
North America was the largest region in the gene expression market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene expression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The main products of gene expressions are kits and reagents, DNA chips or microarrays, and others. Kits and reagents refer to testing kits that are used to detect certain substances by using them in the field or a lab. The major processes involved are sample collection, purification, cDNA synthesis and conversion, PCR analysis, and data analysis and interpretation and techniques including RNA exp, promoter analysis, protein exp., and posttranslational modification analysis, used in various applications such as drug discovery and development, clinical diagnostics, biotechnology and microbiology, and others.
The increased focus on precision medicine is expected to propel the growth of the gene expression market going forward. Precision medicine uses information about an individual's genes or proteins to diagnose, prevent or treat disease. Gene expression is adopted in precision medicine to identify abnormalities in normal function and physiologic regulation of an individual by measuring and comparing the genes and transcripts in tissues with different medical conditions, which helps to provide patient-centric treatment. For instance, in 2021, according to Personalized Medicine Coalition, a US-based professional membership organization representing innovators, scientists, patients, providers, and payers, promotes the understanding and adoption of precision medicines, precision medicines accounted for more than 25% of FDA approvals in the last seven years, and a further 35% of medicine approved in 2021 were precision medicines. Therefore, the increased focus on precision medicine is driving the gene expression market.
Technological advancement is a key trend in the gene expression market. Major companies operating in the gene expression market are advancing toward RNA gene expression technology. For instance, in September 2022, Enzo Biochem, Inc., a US-based leader biosciences and diagnostics company, launched the AMPIVIEW, a new platform designed for superior sensitivity in the detection and visualization of biomarkers in cells and tissue samples. AMPIVIEW™ is an RNA gene expression platform that uses in-situ hybridization technology for detecting HPV and SARS-CoV-2 using specific and sensitive detection of target genes in the tissue or cell while preserving the morphology.
In October 2021, Bionano Genomics Inc., a US-based company operating in gene expression solutions, acquired BioDiscovery for a deal value of $100 million. Through this acquisition, the combined resources of Bionano and BioDiscovery enable the end user with additional information and a full genomic view of the sample. The acquisition is expected to enable Bionano to offer additional structural variations and methylation analysis. BioDiscovery is a US-based company that provides genomic software for clinical and research companies that uses NGS and/or microarrays.
The countries covered in the gene expression market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The gene expression market research report is one of a series of new reports from The Business Research Company that provides gene expression market statistics, including gene expression industry global market size, regional shares, competitors with a gene expression market share, detailed gene expression market segments, market trends and opportunities, and any further data you may need to thrive in the gene expression industry. This gene expression market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.